4//SEC Filing
BAUM MARK L 4
Accession 0001493152-23-025150
CIK 0001360214other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 7:48 PM ET
Size
9.4 KB
Accession
0001493152-23-025150
Insider Transaction Report
Form 4
BAUM MARK L
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Common Stock
2023-07-18+762,300→ 2,309,629 total - Tax Payment
Common Stock
2023-07-18$18.23/sh−299,968$5,468,417→ 2,009,661 total - Exercise/Conversion
Performance Stock Unit
2023-07-18−762,300→ 0 total→ Common Stock (762,300 underlying)
Footnotes (1)
- [F1]The 762,300 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Baum under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 299,968 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 762,300 shares pursuant to the terms of the Incentive Plan.
Documents
Issuer
HARROW HEALTH, INC.
CIK 0001360214
Entity typeother
Related Parties
1- filerCIK 0001274282
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 7:48 PM ET
- Size
- 9.4 KB